Description
OVERVIEWProduct overview
GHRP-6 was among the first synthetic secretagogues described and remains a standard reference compound in ghrelin receptor research.
It is distinguished in the literature by pronounced appetite-related signalling in animal models compared with other peptides in its class.
Research use only; not for human or veterinary use.
SUPPLY IN IRELANDGHRP-6 Acetate Ireland — supplied to research laboratories
Research groups across Ireland buy GHRP-6 Acetate from Kensington Laboratories as a lyophilised GHRP-6 Acetate peptide, released only against a batch-matched certificate of analysis. Every vial of high purity GHRP-6 Acetate is verified by HPLC and LC-MS before it leaves the facility, so laboratories ordering GHRP-6 Acetate in Ireland receive material with documented purity and identity.
Laboratory GHRP-6 Acetate is packed for controlled storage and sent by tracked delivery in 3–5 days to Dublin, Cork, Galway, Limerick and the rest of Ireland. Delivery costs €9.90 per order. Teams planning GHRP6Acetate research can review the specifications, certificate of analysis and reference list on this page before ordering.
Institutions searching for GHRP-6 Acetate peptide suppliers in Ireland typically compare purity, batch documentation and delivery times. Each of those is published here: a 99% HPLC purity specification, a certificate matched to the batch code on your vial, and tracked delivery in 3–5 days.
GHRP-6 Acetate is supplied strictly for laboratory research use only. It is not a medicine and is not for human or veterinary consumption.
SPECIFICATIONSProduct specifications
- Purity: ≥ 99% (HPLC)
- Appearance: White lyophilised powder
- Quantity: 5 mg per vial
- CAS number: 87616-84-0
- Peptide class: Synthetic growth hormone releasing hexapeptide
- Also known as: Growth hormone releasing hexapeptide-6
- Solubility: Soluble in bacteriostatic or sterile water
- Storage temperature: Store at 2–8°C; long-term −20°C, protected from light
- Shelf life: 24 months lyophilised; 30 days reconstituted at 2–8°C
- Manufacturing standard: ISO 9001 facility, GMP-aligned solid-phase synthesis
- Batch information: Batch number and expiry printed on every vial label
RESEARCHResearch overview
The following summary is provided for educational and scientific context only. It describes what has been observed in published laboratory and animal studies and does not represent established clinical outcomes, medical advice or a claim of efficacy in humans.
Background
GHRP-6 was among the first synthetic secretagogues described and remains a standard reference compound in ghrelin receptor research.
It is distinguished in the literature by pronounced appetite-related signalling in animal models compared with other peptides in its class.
Research use only; not for human or veterinary use.
Current research areas
Published investigation clusters around a small number of biological themes. Each remains experimental and none has been established as a therapeutic effect in humans.
- GHS-R1a receptor binding assays
- Appetite and food intake models
- Pituitary secretagogue signalling
- Structure–activity comparison within the GHRP family
Scientific context and proposed mechanisms
The hexapeptide acts at the growth hormone secretagogue receptor, with downstream phospholipase C signalling described in pituitary and hypothalamic tissue.
Hypothalamic receptor engagement is the route authors cite for the appetite effects reported in rodent models.
Interpreting the evidence
Most published work in this area uses cell culture or rodent models with small group sizes and short observation windows. Independent replication varies considerably between compounds, and results are sensitive to species, route, dose and endpoint.
There is no regulatory-approved human protocol for this compound. Any laboratory protocol should be defined by the model under study, institutional ethical approval, appropriate controls and predefined endpoints.
References
CERTIFICATE OF ANALYSISIndependent batch testing
Every released batch is independently tested. Match the batch number on the vial to the certificate published online.
- Batch number
- KL-GHRP6ACETA-2407A
- Testing laboratory
- Janoshik Analytical, s.r.o.
- Date tested
- 2 July 2026
- Reported purity
- 99.42%
- Method
- RP-HPLC with UV detection at 214 nm, confirmed by LC-MS
